WBA
29
4
AMAT
41
-9
LOW
45
2
NWSA
88
10
FCX
40
-3
CHD
50
-6
NKE
39
2
CTSH
54
2
CA
38
9
RSG
77
3
NEM
69
-2
XOM
42
3
ICE
73
-2
ECL
72
2
CMG
57
-3
F
48
6
KMI
53
2
DFS
62
3
AVGO
42
-2
KEY
39
6
WBA
29
4
AMAT
41
-9
LOW
45
2
NWSA
88
10
FCX
40
-3
CHD
50
-6
NKE
39
2
CTSH
54
2
CA
38
9
RSG
77
3
NEM
69
-2
XOM
42
3
ICE
73
-2
ECL
72
2
CMG
57
-3
F
48
6
KMI
53
2
DFS
62
3
AVGO
42
-2
KEY
39
6
Financhill
Back

KB Financial Group Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
32

KB
KB Financial Group

Last Price:
$57.43
Seasonality Move:
0.7%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$105.31
Seasonality Move:
1.75%
Sell
32
KB Financial Group (KB) is a Sell

Is KB Financial Group a Buy, Sell or Hold?

  • The current KB Financial Group [KB] share price is $55.78. The Score for KB is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • KB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KB Stock Price Chart

What is KB Financial Group's stock price today?

  • The KB Financial Group share price today is $55.78
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KB is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

KB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.1 Sell
Relative Strength Index (14 RSI): 30.06 Sell
Chaikin Money Flow: -145621 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.51 - 62.65) Sell
Bollinger Bands (100): (58.99 - 67.11) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

KB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 58.02 Sell
20-day SMA: 60.44 Sell
50-day SMA: 60.01 Sell
200-day SMA: 61.41 Sell
8-day EMA: 57.89 Sell
20-day EMA: 59.39 Sell
50-day EMA: 60.7 Sell
200-day EMA: 59.55 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

KB Financial Group Earnings Growth & KB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $0.65 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

KB Financial Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):